Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
PE3:GRBerlin

Cannonau Corp

COMPANY INFO
1D1M1Y5Y
View Full Chart
No pricing data is available for this time frame
1D1M1Y5Y
View Full Chart
No pricing data is available for this time frame
markets
Deeper OPEC Cuts Would Take Oil Back Above $60: Vanda Insights
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio--
PEGY Ratio--
Shares Outstanding70.51K
Price to Book Ratio--
Price to Sales Ratio--
1 Year Return--
30 Day Avg Volume--
EPS--
Dividend--
Last Dividend Reported--

About Cannonau Corp

Cannonau Corp. operates as a pharmaceutical products. The Company develops cannabidiol based products.
Address
1016 W University Avenue Suite 218 Flagstaff, AZ 86001 United States
Phone
1-602-910-2114

Income Statement

Quarterly
Annual
Sorry, no quarterly data is available at this time.
  • Revenue
    --
  • Net Income
    --
  • Profit Margin
    --%

Balance Sheet

Quarterly
Annual
Sorry, no quarterly data is available at this time.
  • Total Assets
    --
  • Total Liabilities
    --
  • Debt to Assets
    --%

Cash Flow

Quarterly
Annual
Sorry, no quarterly data is available at this time.
  • Operating
    --
  • Investing
    --
  • Financing
    --